So, within the generic companies, from the US point of view, Cipla delivered a very good set of results supported by the ...

In addition to AVT06, which is a biosimilar candidate for Eylea ® (aflibercept) 2 mg, Alvotech is currently also developing AVT29, a biosimilar candidate for Eylea ® HD (aflibercept) 8 mg. Teva also ...

In October 2024, the U.S. Food and Drug Administration (FDA) approved SELARSDI™for all indicationsmatching the reference product ...

In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib ...

BERLIN, February 17, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for the ...

DOC Pharma strengthens its offerings with the acquisition of the Geopharma nutraceuticals portfolio, and the closing of the previously announced acquisition of Muscoril® New brand identity ...

Our vision for our lead asset NOX-A12 remains clear: to secure approval for its use in glioblastoma patients through a strategic partnership with a pharmaceutical company, supported by ...

“Chhapri logo ka favourite festival hota hai holi,” she said. However, her remarks did not sit well with social media users, who accused her of discriminating and demeaning the Hindu festiva ...

Macron has become the official apparel partner for Proteas Women and Men CSA, unveiling a new jersey ahead of the ODI Champions Trophy(Proteas Men @X) As Pakistan and New Zealand prepare for ...

As one of the world’s biggest contributors to climate change, pharma is morally obliged to adapt its processes and operations – and doing so will open up new opportunities for growth.

A sign with the logo is on display at a McDonald's restaurant in Moscow, Russia. (Photo source: Reuters) As Moscow and Washington discuss how to end the war in Ukraine, one of the many questions ...